Journal
CELL STEM CELL
Volume 23, Issue 1, Pages 123-+Publisher
CELL PRESS
DOI: 10.1016/j.stem.2018.06.015
Keywords
-
Categories
Funding
- Bavarian Ministry of Education and Culture, Science, and the Arts
- German Federal Ministry of Education and Research [BMBF: 01GQ113, 01GM1520A, 01EK1609B]
- DFG [GRK2162, 410/45-1]
- Interdisciplinary Centre for Clinical Research
- Bavarian Ministry of Education and Culture, Science and the Arts
- JPB Foundation
- Mathers Foundation
- Lookout Foundation
- Bavaria California Technology Center (BaCaTec)
Ask authors/readers for more resources
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive degeneration of midbrain neurons (MBNs). Recent evidence suggests contribution of the adaptive immune system in PD. Here, we show a role for human T lymphocytes as cell death inducers of induced pluripotent stem cell (iPSC)-derived MBNs in sporadic PD. Higher Th17 frequencies were found in the blood of PD patients and increased numbers of T lymphocytes were detected in postmortem PD brain tissues. We modeled this finding using autologous co-cultures of activated T lymphocytes and iPSC-derived MBNs of sporadic PD patients and controls. After co-culture with T lymphocytes or the addition of IL-17, PD iPSC-derived MBNs underwent increased neuronal death driven by upregulation of IL-17 receptor (IL-17R) and NF kappa B activation. Blockage of IL-17 or IL-17R, or the addition of the FDA-approved anti-IL-17 antibody, secukinumab, rescued the neuronal death. Our findings indicate a critical role for IL-17-producing T lymphocytes in sporadic PD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available